29 Aug, 2026

Investor activism is on the rise in biotech

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. This story first appeared in […]

1 min read

Animal models in medical research are more important than ever

Imagine a world without lifesaving medicines, preventive care, or therapies — no insulin for diabetes, no vaccines for polio, and fewer (if any) options for treating cancer. What do these amazing medical achievements have in common? They all depended heavily on research using animals, the behind-the-scenes heroes of medical breakthroughs. Animal models play a starring […]

6 mins read

FDA approves Novavax Covid vaccine after delay

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on Signal at hbranswell.01. The Food and Drug Administration has finally approved Novavax’s Covid-19 vaccine, but in doing so has placed restrictions on it that its two competitors in […]

1 min read